Somewhere in the next few years, an F1 team will begin sequencing its driver’s gut microbiome before every race weekend. They will not do it because they care about health. They will do it because they have found a correlation between microbial composition and reaction time. Or between gut inflammation and the cognitive drop that costs three-tenths of a second in the final stint. Or between a disrupted microbiome after a transatlantic flight and the two-lap window where the driver’s decision-making quietly degrades.

They will not publish a paper. They will not wait for peer review. They will not convene a committee. They will adjust the driver’s nutrition, modify the pre-race protocol, and measure the result on Sunday. And if it works, it will be standard across the grid in less than a year.

That, I believe, is how the most advanced prototype for personalised medicine will be built. Not in a hospital. Not by a health ministry. On a pit wall in Bahrain, by engineers who could not care less about medicine and care entirely about winning.

This should disturb you. Not because motorsport is overstepping. Because medicine is moving so slowly that a racing team will arrive there first.

Formula 1 already monitors driver physiology with an intensity that no hospital applies to any patient who is not actively dying. Heart rate, core temperature, hydration status, G-force exposure, cognitive load, braking consistency as a proxy for concentration. Every lap generates thousands of data points about a single human body under extreme stress. The teams do not collect these data out of curiosity. They collect it because a tenth of a second is worth millions, and the driver’s body is the one component they cannot replace mid-race.

The microbiome is the next telemetry layer. And the logic that will bring it into F1 is the same logic that should have brought it into medicine a decade ago: the body is a system, not a collection of parts, and one cannot optimise the system if one is ignoring the operating layer that connects everything.

Consider what an F1 team already does that healthcare does not. It integrates data across every system in real time. Aerodynamics, tyres, fuel load, engine temperature, driver physiology. These are not managed by separate departments that convene once a quarter. They are managed simultaneously, by a team that makes decisions in seconds based on how the systems interact. A tyre strategy changes because the engine is running hot, which changes the stint length, which changes the fuel load, which changes the driver’s hydration plan. Everything communicates with everything. That is how one manages a complex system.

Now look at human health. Cardiology does not speak to gastroenterology. Gastroenterology does not speak to psychiatry. Nutrition is a pamphlet handed out at discharge. The microbiome, which modulates immune function, metabolic response, neurological signalling, and drug metabolism simultaneously, has no department at all. We manage the most complex biological system on the planet the way a racing team would operate if the engine crew, the tyre crew, and the strategist were in different buildings and met only at the end of the season.

On ne gagne pas un Grand Prix en optimisant un seul boulon. On ne gagnera pas la bataille de la santé en optimisant un seul organe.

You do not win a Grand Prix by optimising a single bolt. You will not win the battle for health by optimising a single organ.

The reason F1 will arrive there first is not technology. Medicine possesses better technology. The reason is the incentive structure. In Formula 1, the feedback loop is immediate and unforgiving. A decision made on the pit wall produces a measurable result within minutes. There is no ambiguity about whether it worked. There is no twenty-year longitudinal study. There is a stopwatch.

In medicine, the feedback loops are so long and so diffuse that one can ignore a signal for decades and face no consequence. A dietary guideline can be wrong for an entire generation and the system that produced it will still be in place when the evidence finally arrives. A microbiome intervention that could shift a patient’s inflammatory trajectory will not be adopted until it has passed through a regulatory process designed for pharmaceuticals, reviewed by specialists who were not trained to think in systems, and funded by a structure that reimburses procedures, not prevention. F1 does not suffer from this problem. If the data says the driver’s gut is affecting performance, the team will act on it this weekend. Not next year. Not after a phase 3 trial. This weekend.

And here is where it becomes a health story whether the teams intend it or not. The protocols they develop for twenty drivers will produce the most detailed, most integrated, most longitudinally tracked dataset on the relationship between microbiome composition and human performance ever assembled. Not because anyone planned it as research. Because the competitive logic demanded it. Every race weekend becomes a controlled experiment. Every dietary adjustment becomes an intervention with a measurable outcome. Every transatlantic flight becomes a natural perturbation study.

That data will leak. It always does. First to other elite sports. Then to high-performance corporate wellness. Then to consumer health platforms. Then to clinical medicine, arriving last as usual, repackaged as a cautious innovation and presented as though the institution had been working on it all along.

The irony is precise. The future of personalised medicine will not be designed by the people responsible for health. It will be designed by people responsible for lap times. And it will work, because they never confused managing a system with managing its parts.

We are entering a period where the most important health innovations will emerge from outside health. From racing. From agriculture. From urban design. From anywhere the incentive to understand biological systems is immediate and the penalty for ignoring complexity is felt in real time. Medicine will adopt these innovations eventually. It always does. The question is how many years it will waste pretending they are not relevant, while the data accumulates on a pit wall somewhere in the desert.

La médecine du futur ne viendra pas de la médecine. Elle viendra de ceux qui n’ont pas le luxe d’attendre.

The medicine of the future will not come from medicine. It will come from those who do not have the luxury of waiting.

If you work for an F1 team and this resonates, I would be glad to help you build this new layer of telemetry. 

Et voilà.